By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Integrase strand transfer inhibitor > Apretude
Integrase strand transfer inhibitor

Apretude

https://themeditary.com/drug/apretude-4193.html
Medically Reviewed by Judith Stewart, BPharm TheMediTary.Com | Reviewed: Aug 05, 2023  Additional Content by TheMediTary.Com

Generic name: cabotegravir

Drug class: Integrase strand transfer inhibitor

Dosage form: extended-release injectable suspension for intramuscular use

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Vocabria, Cabotegravir, Cabotegravir (systemic) (monograph)

Contents
Uses Warnings Before Taking Dosage Side effects Interactions
  • Apretude (Cabotegravir)-medicine-600 mg/3 mL (200 mg/mL) injection Apretude 600 mg/3 mL (200 mg/mL) injection (medicine)
  • Apretude (Cabotegravir)-medicine-600 mg/3 mL (200 mg/mL) injection Apretude 600 mg/3 mL (200 mg/mL) injection (medicine)
  • View all images

What is Apretude?

Apretude is a prescription medicine used for HIV-1 PrEP to reduce the risk of getting HIV-1 infection in adults and adolescents who weigh at least 77 pounds (at least 35 kg).

HIV-1 is the virus that causes Acquired Immune Deficiency Syndrome (AIDS).

It is not known if this medicine is safe and effective in children younger than 12 years of age or weighing less than 77 pounds (less than 35 kg).

Warnings

Important information for people who receive Apretude to help reduce their risk of getting human immunodeficiency virus-1 (HIV-1) infection, also called pre exposure prophylaxis or “PrEP”:

Before receiving Apretude to reduce your risk of getting HIV-1:

  • You must be HIV-1 negative to start Apretude. You must get tested to make sure that you do not already have HIV-1 infection.
  • Do not receive Apretude for HIV-1 PrEP unless you are confirmed to be HIV-1 negative.
  • Some HIV-1 tests can miss HIV-1 infection in a person who has recently become infected. If you have flu-like symptoms, you could have recently become infected with HIV-1. Tell your healthcare provider if you had a flu-like illness within the last month before starting Apretude or at any time while receiving Apretude. Symptoms of new HIV-1 infection include:
    • tiredness
    • joint or muscle aches
    • sore throat
    • rash
    • enlarged lymph nodes in the neck or groin
    • fever
    • headache
    • vomiting or diarrhea
    • night sweats

While you are receiving Apretude for HIV-1 PrEP:

  • Apretude does not prevent other sexually transmitted infections. Practice safer sex by using a latex or polyurethane condom to reduce the risk of getting sexually transmitted infections.
  • You must stay HIV-1 negative to keep receiving Apretude for HIV-1 PrEP.
    • Know your HIV-1 status and the HIV-1 status of your partners.
    • Ask your partners with HIV-1 if they are taking anti-HIV-1 medicines and have an undetectable viral load. An undetectable viral load is when the amount of virus in the blood is too low to be measured in a lab test. To maintain an undetectable viral load, your partners must keep taking HIV-1 medicine as prescribed. Your risk of getting HIV-1 is lower if your partners with HIV-1 are taking effective treatment.
    • Get tested for HIV-1 with each Apretude injection or when your healthcare provider tells you. You should not miss any HIV-1 tests. If you become HIV-1 infected and continue receiving Apretude because you do not know you are HIV-1 infected, the HIV-1 infection may become harder to treat.
    • Get tested for other sexually transmitted infections such as syphilis, chlamydia, and gonorrhea. These infections make it easier for HIV-1 to infect you.
    • If you think you were exposed to HIV-1, tell your healthcare provider right away. They may want to do more tests to be sure you are still HIV-1 negative.
    • Get information and support to help reduce sexual risk behaviors.
    • Do not miss any injections of Apretude. Missing injections increases your risk of getting HIV-1 infection.
    • If you do become HIV-1 positive, you will need to take other medicines to treat HIV-1. Apretude is not approved for treatment of HIV-1.

If you have HIV-1 and receive only Apretude, over time your HIV-1 may become harder to treat.

How should I take Apretude

  • Apretude is initially given as an injection into the muscle of your buttock 1 time every month for the first 2 months, then as an injection 1 time every 2 months.
  • Before receiving your first injection dose of Apretude, your healthcare provider may have you take 1 oral cabotegravir tablet 1 time a day for 1 month (at least 28 days). This will allow your healthcare provider to assess how well you will tolerate cabotegravir.
  • Apretude is a long-acting medicine and may stay in your body for 12 months or longer after your last injection.
  • Stay under the care of a healthcare provider while receiving Apretude. It is important that you receive Apretude as scheduled.
  • If you miss or plan to miss a scheduled injection of Apretude by more than 7 days, call your healthcare provider right away to discuss your PrEP options.
  • If you stop receiving Apretude, talk to your healthcare provider about other options to reduce the risk of getting HIV-1 infection.

Dosing information

Usual Adult Dose for HIV-1 PrEP

- Initiate Apretude with a single 600-mg (3-mL) injection given 1 month apart for 2 consecutive months on the last day of an oral lead-in if used or within 3 days and continue with the injections every 2 months thereafter.

- Use: at-risk adults and adolescents weighing at least 35 kg for PrEP to reduce the risk of sexually acquired HIV-1 infection. Individuals must have a negative HIV-1 test prior to initiating Apretude (with or without an oral lead-in with oral cabotegravir) for HIV-1 PrEP.

Detailed Apretude dosage information
Apretude Dosage information (more detail)

Before Taking

You should not receive Apretude if you:

  • already have HIV-1 infection. If you are HIV-1 positive, you will need to take other medicines to treat HIV-1. Apretude is not approved for treatment of HIV-1.
  • do not know your HIV-1 infection status. You may already be HIV-1 positive. You need to take other medicines to treat HIV-1. Apretude can only help reduce your risk of getting HIV-1 infection before you are infected.
  • are allergic to cabotegravir
Apretude pregnancy and breastfeeding warnings (more detail)

Before receiving Apretude

Before receiving Apretude, tell your healthcare provider about all your medical conditions, including if you:

  • have ever had a skin rash or an allergic reaction to medicines that contain cabotegravir.
  • have or have had liver problems.
  • have ever had mental health problems.
  • are pregnant or plan to become pregnant. It is not known if Apretude will harm your unborn baby. Apretude can remain in your body for up to 12 months or longer after the last injection. Tell your healthcare provider if you become pregnant while receiving Apretude.
    Pregnancy Registry. There is a pregnancy registry for women who receive Apretude during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk to your healthcare provider about how you can take part in this registry.
  • are breastfeeding or plan to breastfeed. It is not known if Apretude can pass to your baby in your breast milk. Talk with your healthcare provider about the best way to feed your baby while receiving Apretude.

Apretude side effects

Apretude may cause serious side effects including:

  • Allergic reactions. Call your healthcare provider right away if you develop a rash with Apretude.
    Stop receiving Apretude and get medical help right away if you develop a rash with any of the following signs or symptoms:
    • fever
    • generally ill feeling
    • tiredness
    • muscle or joint aches
    • trouble breathing
    • blisters or sores in mouth
    • blisters
    • redness or swelling of the eyes
    • swelling of the mouth, face, lips, or tongue
  • Liver problems. Liver problems have happened in people with or without a history of liver problems or other risk factors. Your healthcare provider may do blood tests to check your liver function.

Call your healthcare provider right away if you develop any of the following signs or symptoms of liver problems:

    • your skin or the white part of your eyes turns yellow (jaundice)
    • dark or “tea-colored” urine
    • light-colored stools (bowel movements)
    • nausea or vomiting
    • loss of appetite
    • pain, aching, or tenderness on the right side of your stomach area
    • itching
  • Depression or mood changes. Call your healthcare provider or get medical help right away if you have any of the following symptoms:
    • feeling sad or hopeless
    • feeling anxious or restless
    • have thoughts of hurting yourself (suicide) or have tried to hurt yourself

The most common side effects include:

  • pain, tenderness, hardened mass or lump, swelling, bruising, redness, itching, warmth, loss of sensation at the injection site, abscess, and discoloration
  • diarrhea
  • headache
  • fever
  • tiredness
  • sleep problems
  • nausea
  • dizziness
  • passing gas
  • stomach pain
  • vomiting
  • muscle pain
  • rash
  • loss of appetite
  • drowsiness
  • back pain
  • upper respiratory infection

These are not all the possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800 FDA1088.

See more: Apretude Side Effects

What other drugs will affect Apretude?

Tell your healthcare provider about all the medicines you take, including prescription and over-thecounter medicines, vitamins, and herbal supplements. Some medicines may interact with Apretude. Keep a list of your medicines and show it to your healthcare provider and pharmacist when you get a new medicine.

You can ask your healthcare provider or pharmacist for a list of medicines that interact with Apretude.

Do not receive Apretude if you are taking any of the following medicines:

  • carbamazepine
  • oxcarbazepine
  • phenobarbital
  • phenytoin
  • rifampin
  • rifapentine

Do not start a new medicine without telling your healthcare provider. Your healthcare provider can tell you if it is safe to receive Apretude with other medicines.

More about Apretude (Cabotegravir)

Dosage information
Apretude Side Effects
During pregnancy
Apretude Prescribing Information
Drug images
Side effects
Drug class: Integrase strand transfer inhibitor

Related treatment guides

Pre-Exposure Prophylaxis
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by